-
European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy as Adjuvant Treatment, for Resectable Non-Small Cell Lung Cancer (NSCLC) at High Risk of Recurrence in Adults
28 Mar 2024 11:00 GMT
… well as Iceland, Liechtenstein, Norway and Northern … etiologies, including infection. Institute medical management promptly, … (11%).
Geriatric Use
Of the 564 patients with locally … treatment of patients with recurrent or metastatic HNSCC with disease …
-
European Commission Approves Pfizer’s TALZENNA® in Combination with XTANDI® for Adult Patients with Metastatic Castration-Resistant Prostate Cancer
08 Jan 2024 15:42 GMT
… states plus Iceland, Liechtenstein, and Norway.
… effective treatment that addresses disease progression in patients with … patients, including pneumonia, COVID infection, and sepsis (1 patient … and Alzheimer’s disease, meningioma, or leptomeningeal disease from …
-
FDA Approves LONSURF® (trifluridine/tipiracil) in Combination With Bevacizumab for Adult Patients With Metastatic Colorectal Cancer (mCRC)
02 Aug 2023 23:10 GMT
… treatment landscape for this patient population," said Marwan Fakih, MD, Professor, Medical … risk reduction of disease progression.1
Results … Iceland, Northern Ireland, Liechtenstein and Norway.
About … the final dose.
Geriatric Use: Patients 65 years of …
-
ACRS Soars On RA Trial Data, BHVN Disappoints In Alzheimer's Trial, GRTS Joins COVID-19 Vaccine Race
20 Jan 2021 05:44 GMT
… to-moderate Alzheimer';s disease, Troriluzole did … progress of Alzheimer';s medications. A U.S … Infectious Diseases Clinical Research Consortium, with … Liechtenstein, Iceland, and Norway.
A phase III trial of Seltorexant for the treatment …
-
The treatment that Trump touted as a ‘cure’ for Covid-19 was developed using cells derived from fetal tissue.
08 Oct 2020 18:09 GMT
… of the Centers for Disease Control and Prevention, said … the amount of virus in an infected person’s body … Europe, for the treatment of Covid-19 patients needing supplemental oxygen. … the United Kingdom, Iceland, Liechtenstein, Norway and several Balkan …
-
European Commission Approves EVENITY® (romosozumab) For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture
12 Dec 2019 10:14 GMT
… services, lifestyles and medicines," said Alison … (Norway, Iceland and Liechtenstein). EVENITY is now approved … dental disease or infection, anemia and coagulopathy.
For patients requiring … .
During EVENITY® treatment, patients should be advised to …
-
Merck Receives EU CHMP Positive Opinion for Investigational V920 Ebola Zaire Vaccine for Protection Against Ebola Virus Disease
18 Oct 2019 12:08 GMT
… , Iceland, Liechtenstein and Norway. … from Ebola virus disease to … treatments, or benefit patients without treatment options. These medicines are considered priority medicines … diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases …
-
Merck Receives Positive EU CHMP Opinion for ZERBAXA® 3g Dose (ceftolozane and tazobactam) for the Treatment of Adults with Hospital-Acquired Pneumonia (HAP), Including Ventilator-Associated Pneumonia (VAP)
29 Jul 2019 20:30 GMT
… Liechtenstein and Norway. Supplemental marketing authorization applications for ZERBAXA for the treatment … medical professionals treating critically ill patients … diseases, emerging animal diseases, Alzheimer';s disease and infectious diseases including …
-
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Abecma (idecabtagene vicleucel) in Earlier Lines of Therapy for Triple-Class Exposed Relapsed and Refractory Multiple Myeloma
26 Jan 2024 12:25 GMT
… , Norway and Liechtenstein.* Please see … patients following treatment with ABECMA. Do not administer ABECMA to patients with active infection … patient, Grade 3 myelitis, and Grade 3 parkinsonism … medicines that help patients prevail over serious diseases. …
-
EMD Serono - John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
11 Dec 2017 13:14 GMT
… several disease areas, including multiple sclerosis (MS), Alzheimer… Liechtenstein and Iceland. In December 2017, Health Canada approved MAVENCLAD for the treatment … treatment to patients with relapsing forms of MS, who have experienced breakthrough disease …